5 Clinical studies using GABA in diabetes 5.1 GABA and GABA/GAD65-alum clinical trial in children with recent onset T1D The GABA and GABA/GAD65 trial (82) was the first human, prospective, double blind, placebo-controlled and randomized clinical trial of oral GABA (with and without GAD65-alum) in new onset type 1 childhood diabetes
Effects of pharmacologic and nonpharmacologic interventions on menopause-related quality of life: a pooled analysis of individual participant data from four MsFLASH trials
Clinical trial data indicates tesofensine-induced weight loss consists predominantly of fat mass loss with notable preservation of lean body mass, a critical distinction from general caloric restriction which typically results in proportional loss of both fat and muscle tissue
10.3233/ADR-190125 71 Dumitru GE.-N
The NOVA classification system provides a useful framework
Lheureux PE, Penaloza A, Zahir S, Gris M: Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence